174 related articles for article (PubMed ID: 38732010)
1. A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from
Andrade KCR; Homem-de-Mello M; Motta JA; Borges MG; de Abreu JAC; de Souza PM; Pessoa A; Pappas GJ; de Oliveira Magalhães P
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732010
[TBL] [Abstract][Full Text] [Related]
2. Decreasing the immunogenicity of Erwinia chrysanthemi asparaginase via protein engineering: computational approach.
Yari M; Eslami M; Ghoshoon MB; Nezafat N; Ghasemi Y
Mol Biol Rep; 2019 Oct; 46(5):4751-4761. PubMed ID: 31290058
[TBL] [Abstract][Full Text] [Related]
3. In silico identification and characterization of antineoplastic asparaginase enzyme from endophytic bacteria.
Zadeh Hosseingholi E; Neghabi N; Molavi G; Gheibi Hayat SM; Shahriarpour H
IUBMB Life; 2020 May; 72(5):991-1000. PubMed ID: 31981306
[TBL] [Abstract][Full Text] [Related]
4. Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.
Huerta-Saquero A; Evangelista-Martínez Z; Moreno-Enriquez A; Perez-Rueda E
Bioengineered; 2013; 4(1):30-6. PubMed ID: 22895060
[TBL] [Abstract][Full Text] [Related]
5. Studies on Deimmunization of Antileukaemic L-Asparaginase to have Reduced Clinical Immunogenicity--An in silico Approach.
Ramya LN; Pulicherla KK
Pathol Oncol Res; 2015 Sep; 21(4):909-20. PubMed ID: 25740072
[TBL] [Abstract][Full Text] [Related]
6. A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora.
Belén LH; Lissabet JB; de Oliveira Rangel-Yagui C; Effer B; Monteiro G; Pessoa A; Farías Avendaño JG
Biologicals; 2019 May; 59():47-55. PubMed ID: 30871932
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
[TBL] [Abstract][Full Text] [Related]
8. Mapping of B-cell epitopes in E. coli asparaginase II, an enzyme used in leukemia treatment.
Werner A; Röhm KH; Müller HJ
Biol Chem; 2005 Jun; 386(6):535-40. PubMed ID: 16006240
[TBL] [Abstract][Full Text] [Related]
9. In vitro screening and in silico validation revealed key microbes for higher production of significant therapeutic enzyme l-asparaginase.
Vimal A; Kumar A
Enzyme Microb Technol; 2017 Mar; 98():9-17. PubMed ID: 28110669
[TBL] [Abstract][Full Text] [Related]
10. A potential type-II L-asparaginase from marine isolate Bacillus australimaris NJB19: Statistical optimization, in silico analysis and structural modeling.
Chakravarty N; Priyanka ; Singh J; Singh RP
Int J Biol Macromol; 2021 Mar; 174():527-539. PubMed ID: 33508362
[TBL] [Abstract][Full Text] [Related]
11. Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzyme.
Gervais D; Foote N
Mol Biotechnol; 2014 Oct; 56(10):865-77. PubMed ID: 24870616
[TBL] [Abstract][Full Text] [Related]
12. Kinetic studies of L-asparaginase from Penicillium digitatum.
Shrivastava A; Khan AA; Shrivastav A; Jain SK; Singhal PK
Prep Biochem Biotechnol; 2012; 42(6):574-81. PubMed ID: 23030468
[TBL] [Abstract][Full Text] [Related]
13. The cross-reactivity of anti-asparaginase antibodies against different L-asparaginase preparations.
Zalewska-Szewczyk B; Gach A; Wyka K; Bodalski J; Młynarski W
Clin Exp Med; 2009 Jun; 9(2):113-6. PubMed ID: 19184328
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive review on microbial l-asparaginase: Bioprocessing, characterization, and industrial applications.
Chand S; Mahajan RV; Prasad JP; Sahoo DK; Mihooliya KN; Dhar MS; Sharma G
Biotechnol Appl Biochem; 2020 Jul; 67(4):619-647. PubMed ID: 31954377
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, structural modeling and production of recombinant Aspergillus terreusl. asparaginase in Escherichia coli.
Saeed H; Ali H; Soudan H; Embaby A; El-Sharkawy A; Farag A; Hussein A; Ataya F
Int J Biol Macromol; 2018 Jan; 106():1041-1051. PubMed ID: 28851634
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Catalysis by l-Asparaginase.
Lubkowski J; Vanegas J; Chan WK; Lorenzi PL; Weinstein JN; Sukharev S; Fushman D; Rempe S; Anishkin A; Wlodawer A
Biochemistry; 2020 May; 59(20):1927-1945. PubMed ID: 32364696
[TBL] [Abstract][Full Text] [Related]
17. In Silico Design of a Chimeric Humanized L-asparaginase.
Pedroso A; Herrera Belén L; Beltrán JF; Castillo RL; Pessoa A; Pedroso E; Farías JG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108713
[TBL] [Abstract][Full Text] [Related]
18. Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.
Moola ZB; Scawen MD; Atkinson T; Nicholls DJ
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):921-7. PubMed ID: 7945221
[TBL] [Abstract][Full Text] [Related]
19. Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?
Maese L; Rizzari C; Coleman R; Power A; van der Sluis I; Rau RE
Pediatr Blood Cancer; 2021 Oct; 68(10):e29169. PubMed ID: 34105243
[TBL] [Abstract][Full Text] [Related]
20. Sequencing and characterization of an L-asparaginase gene from a new species of Penicillium section Citrina isolated from Cerrado.
Andrade KCR; Fernandes RA; Pinho DB; de Freitas MM; Filho EXF; Pessoa A; Silva JI; Magalhães PO
Sci Rep; 2021 Sep; 11(1):17861. PubMed ID: 34504186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
